Teladoc Health Inc (NYSE:TDOC) price on Wednesday, February 05, rose 5.77% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $11.00.
A look at the stock’s price movement, the close in the last trading session was $10.40, moving within a range at $10.47 and $11.44. The beta value (5-Year monthly) was 0.9. Turning to its 52-week performance, $21.74 and $6.76 were the 52-week high and 52-week low respectively. Overall, TDOC moved 15.55% over the past month.
Teladoc Health Inc’s market cap currently stands at around $1.89 billion, with investors looking forward to this quarter’s earnings report slated for in March.
Analysts have a consensus estimate of 639.44M for the company’s revenue for the quarter, with a low and high estimate of 632.34M and 673.75M respectively. The average forecast suggests down to a -3.19% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 2.57B, representing a -1.31% decline on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that TDOC is a 50% Buy. On the other hand, the stock is on average a 100% Buy as suggested by medium term indicators while long term indicators are putting the stock in 50% Buy category.
19 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 10 analyst(s) rate the stock as a Hold, 9 recommend TDOC as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Hold which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
TDOC’s current price about 10.59% and 8.30% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 65.39, while 7-day volatility ratio is 6.00% and 5.88% in the 30-day chart. Further, Teladoc Health Inc (TDOC) has a beta value of 1.27, and an average true range (ATR) of 0.59. Analysts have given the company’s stock an average 52-week price target of $11, forecast between a low of $9 and high of $13. Looking at the price targets, the low is 18.18% off current price level while to achieve the yearly target high, price needs to move -18.18%. Nonetheless, investors will most likely welcome a 0.0% jump to $11 which is the analysts’ median price.
If we refocus on Teladoc Health Inc (NYSE:TDOC), historical trading data shows that trading volumes averaged 3.81 over the past 10 days and 4.88 million over the past 3 months. The company’s latest data on shares outstanding shows there are 171.94 million shares.
The 2.12% of Teladoc Health Inc’s shares are in the hands of company insiders while institutional holders own 73.27% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 23.5 million on 2025-01-15, giving us a short ratio of 5.57. The data shows that as of 2025-01-15 short interest in Teladoc Health Inc (TDOC) stood at 1770.0 of shares outstanding, with shares short rising to 22.71 million registered in 2024-12-13. Current price change has pushed the stock 21.01% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the TDOC stock continues to rise going into the next quarter.
